Use of intraoperative insulin assay for the localisation of insulinoma.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 19225834.
- Also identified by DOI 10.1007/s00268-009-9946-0.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The curative treatment for patients with insulinoma is the surgical removal of the tumour; however, these tumours are small and therefore their preoperative localisation using ultrasound and CT scans may be difficult. Intraoperative serum insulin measurements were used as an aid to the surgical management of seven unselected and consecutive presentations of insulinoma. In six of the seven cases we were able to demonstrate an increase in the peripheral serum insulin concentration between 3 and 5 min after manual examination of the tumour. In addition, there was a 50% decrease in concentration 10 min after removal of the tumour. We believe that intraoperative insulin measurements are of use in demonstrating the functionality of tumours localised by intraoperative ultrasound and surgical examination. In addition, they act as an indicator of the completeness of surgery post tumour excision.
Medical subject headings
- Biomarkers, Tumor
- Insulin
- Insulinoma
- Intraoperative Care
- Pancreatic Neoplasms